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The use of stilbenes has been proposed as an alternative to sulfur dioxide in wine. 29 
Provided the feasibility from a technological approach, the cytotoxicity of an extract 30 
from grapevine shoots containing a stilbene richness of 99% (ST-99 extract) was 31 
assessed in the human cell lines HepG2 and Caco-2. In addition, the effects of the 32 
main stilbenes found in ST-99, trans-resveratrol and trans-ε-viniferin were studied, as 33 
well as its mixture. Similar cytotoxic effects were obtained in the exposures to trans-ε-34 
viniferin, ST-99 and the mixture; however, trans-resveratrol alone exerted less toxicity. 35 
When HepG2 cells were exposed to trans-ε-viniferin, ST-99 and the mixture, the mean 36 
effective concentration (EC50) were 28.28 ± 2.15, 31.91 ± 1.55 and 29.47 ± 3.54 µg/mL, 37 
respectively. However, in the exposure to trans-resveratrol, the EC50 was higher 38 
50µ/mL. The morphological study evidenced damage at ultrastructural level in HepG2 39 
cells, highlighting the inhibition of cell proliferation and the induction of apoptosis. The 40 
type of interaction produced by trans-ε-viniferin and trans-resveratrol mixtures was 41 
assessed by an isobologram analysis using the CalcuSyn software, evidencing an 42 
antagonist effect. These data comprise a starting point in the toxicological assessment; 43 
further studies are needed in this field to assure the safety of the extract ST-99. 44 
 45 





1. Introduction 48 
The most widely used preservative in wine industry is sulfur dioxide (SO2). However, 49 
many side effects have been attributed to SO2 in sensitive human such as dermatitis, 50 
urticarial, angioedema, diarrhea, abdominal pain, bronchoconstriction, and anaphylaxis 51 
(Guerrero et al., 2015). In addition, the European Food Safety Authority (EFSA) has 52 
recently recommended that the temporary group acceptable daily intake (ADI) for SO2 53 
should be re-evaluated (EFSA, 2016a). The Panel also concluded that exposure 54 
estimates to SO2 and sulfites were higher than the group ADI of 0.7 mg SO2 55 
equivalent/kg bw per day for all population groups. Moreover, consumers demand 56 
products containing natural ingredients, due to an increase in green awareness. 57 
Considering all this background, the wine industry is searching for new alternatives to 58 
SO2 trying to avoid synthetic preservatives. One of the most promising alternatives is 59 
the use of phenolic compounds. Natural extracts rich in stilbenes have been assayed 60 
for this purpose (Raposo et al., 2016). Grapevine shoot are particularly rich in 61 
stilbenes, with trans-resveratrol and trans-ε-viniferin present in considerably high 62 
amounts (Anastasiadi et al., 2012; Guerrero et al., 2016), showing high antioxidant and 63 
antimicrobial properties (Biais et al., 2017; Müller et al., 2009; Ruiz-Moreno et al., 64 
2015). In fact, previous studies carried out in our laboratory have checked the safety 65 
and usefulness of a stilbene extract containing 45.4% of stilbenes (Medrano-Padial et 66 
al., 2019). Further processes were able to obtain an extract with higher percentage of 67 
stilbenes (99%) named ST-99, which has proved to have good properties to be used as 68 
preservative in wines (data non-published). The next step is now to check its safety 69 
regarding consumers.  70 
The EFSA in the guidance on safety assessment of botanicals and botanical 71 
preparations intended for use as ingredients in food supplements (EFSA, 2009) 72 
advises that the studies to probe their safety should be carried out in accordance with 73 




first step should be in vitro studies. Moreover, in chemical mixture toxicology, it is 75 
essential first to evaluate the toxicity profile with in vitro approaches that will provide 76 
important information related to the mode of action (Hernandez et al., 2019). Therefore, 77 
the present work aims to assess the cytotoxicity of the ST-99 extract in two human cell 78 
lines, HepG2 (liver hepatocellular cells) and Caco-2 (epithelial colorectal 79 
adenocarcinoma cells). The toxicity of synthetic trans-resveratrol is well characterized 80 
as summarized in the scientific opinion about its safety to be used as a novel food 81 
(EFSA, 2016b). The Panel concludes that synthetic trans-resveratrol does not raise 82 
safety concerns at the intended intake level of 150 mg/day for adults. The toxicity of 83 
trans-ε-viniferin has been faintly studied so far. Some of the authors studying the effect 84 
of this compound reported no cytotoxic effect of trans-ε-viniferin at low concentrations. 85 
Hence, Richard et al. (2011) evidenced that trans-ε-viniferin glucoside did not 86 
significantly affect the viability in the neuronal cells PC12 exposed up to 10 µM. 87 
Similarly, trans-ε-viniferin had no cytotoxic effect on neurons and astrocytes at 88 
concentrations lower than 10 μM. Indeed, they found that trans-ε-viniferin preserved 89 
neuronal integrity at 1µM (Vion et al., 2018). The cytotoxicity activity of trans-ε-viniferin 90 
against mouse lymphoma cells (P-388) revealed a half-maximal inhibitory 91 
concentration (IC50) of 18.1±0.7 µM (Muhtadi et al., 2006). Moreover, Nivelle et al. 92 
(2018) demonstrates that trans-ε-viniferin present antitumoral activities on human 93 
melanoma cells without toxicity on normal human dermal fibroblasts at concentrations 94 
of 60-85 µM. 95 
Consumers are exposed to stilbenes by ingestion of different foods that naturally 96 
contain them, such as wines, berries, peanut and its derivatives, pistachio, nuts , dark 97 
chocolate, and grapes and their derivatives and herbal plants contain (Baur and 98 
Sinclair, 2006; Bavaresco et al., 2016; Guerrero et al., 2009; 2020). In this sense, the 99 
amount of stilbenes daily intake is highly different around the world according to the 100 




industry, the intake of these stilbenes may increase, and consequently an accurate 102 
toxicological assessment is required.  103 
Hence, the present work studied the cytotoxicity of the most relevant biologically active 104 
constituents found in a grapevine shoot extract; trans-resveratrol and trans-ε-viniferin, 105 
were also performed, alone and in a mixture of both with the same proportion found in 106 
the extract (1:3.9). In addition, the effects of their combinations were studied by an 107 
isobologram analysis in order to detect potential interactions between both stilbenes. 108 
Moreover, the ultrastructural study performed in both cell lines exposed to the extract 109 
and the mixture of stilbenes helped to clarify in the mechanism of action of the extract.  110 
 111 
2. Materials and methods 112 
2.1. Supplies and chemicals  113 
Culture medium, fetal bovine serum and cell culture reagents were obtained from 114 
Gibco (Biomol, Sevilla, Spain). Chemicals for the different assays were provided by 115 
Sigma-Aldrich (Madrid, Spain), (Biotech Ibérica, Madrid, Spain) and VWR International 116 
Eurolab (Barcelona, Spain).  117 
Trans-resveratrol was provided by Sigma–Aldrich (≥99% pure as determined by 118 
HPLC). Trans-ε-viniferin was obtained from grapevine stems harvested in Bordeaux 119 
region (France) and were composed of a mixture of Merlot and Cabernet Sauvignon 120 
varieties of Vitis vinifera. Trans-ε-viniferin (98%) was purified by preparative HPLC as 121 
reported by Gabaston et al. (2018).  122 
 123 
2.2. Grapevine-shoot extract preparation and test solutions 124 
The protocol used to obtain the grapevine-shoot extract was reported in a previous 125 
work (Gabaston et al., 2018). Dried and finely ground vineshoot of V. vinifera cv. were 126 
extracted with acetone–water (6:4, v/v) at room temperature under agitation, twice for 127 




and lyophilisated. Finally, the extract was deposited on an Amberlite XAD-7 column 129 
and washed with water. The column was then eluted with acetone. The solvent was 130 
evaporated until dryness. The extract was first solved in Arizona K solvents and 131 
filtrated. Furthermore, the extract was fractionated by centrifugal partition 132 
chromatography (CPC) and analyzed by UHPLC-MS using the method developed by 133 
Biais et al. (2017). The stilbene fraction enriched in trans-resveratrol and trans-ε-134 
viniferin was collected and named ST-99. The ST-99 extract contained at least 99% of 135 
total stilbenes (w/w), being the main stilbenes found trans-ε-viniferin (70%) and trans-136 
resveratrol (18%). Other stilbenes found in a lower percentage are vitisin B (4%), w-137 
viniferin (4%), cis-ε-viniferin (1%), miyabenol C (1.5%), and cis-resveratrol (0.5%)  138 
The range of the extract and trans-ε-viniferin concentrations for the cytotoxicity tests 139 
was selected considering the concentration to be incorporated in wine (100 mg/L). 140 
However, in the case of trans-resveratrol, the maximum concentration used was 50 141 
µg/mL because it was the highest concentration showing adequate solubility and it is 142 
within the concentration range of this compound that will reach the consumer. Serial 143 
test solutions (0-100 µg/mL) were prepared from stock solution (1000 µg/mL) in 144 
dimethylsulfoxide (DMSO), being the final concentration in DMSO below 0.5%.  145 
 146 
2.3. Model systems  147 
The Caco-2 cell line derived from a human colon carcinoma (HTB-37) and HepG2, a 148 
human hepatocellular carcinoma epithelial cell line (HB-8065), were maintained at 149 
37ºC in an atmosphere containing 5% CO2 at 95% relative humidity (CO2 incubator, 150 
Nuaire®, Spain). Caco-2 cells were cultured in a medium consisting of Eagle’s medium 151 
(EMEM) supplemented with 20% foetal bovine serum (FBS), 1% non-essential amino 152 
acids, 50 g/ml gentamicin, 2 mM L-glutamine and 1 mM pyruvate. HepG2 cells were 153 




and 2 mM L-glutamine. Cells were grown 80% confluent in 75-cm2 plastic flasks and 155 
harvested 3 times weekly (1:2 split ratio) with 0.25% trypsin. 156 
 157 
2.4. Cytotoxicity assays 158 
For the cytotoxicity assays, both cell lines were seeded in 96-well culture plates.  159 
HepG2 cells were plated at density of 5 x 104 cells/ well and Caco-2 cells at 7.5 × 105 160 
cells/ well to perform the experiments. 161 
A wide range of concentrations in medium was prepared from the initial solution of 100 162 
µg/ml. Culture medium without the extract was used as a control group. A control of 163 
solvent (0.5% of DMSO) was also included. The cytotoxicity assays were performed in 164 
cells exposed for 24 h and 48 h to ST-99 extract, trans-resveratrol, trans-ε-viniferin and 165 
the mixture of both stilbenes in the same ratio that they are found in the extract 166 
(1:3.9).Neutral red uptake (NR) was measured as described in Borenfreund & Puerner 167 
(1984). MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-168 
sulfophenyl)-2H-tetrazolium salt) reduction was evaluated according to Baltrop et al. 169 
(1991). The protein content (PC) assay was performed according to the procedure 170 
given by Bradford (1976). 171 
 172 
2.5. Assessment of the effect of stilbenes combination by the isobolograms method 173 
In order to assess the effect of the stilbene’s combination, cells were exposed to 174 
different concentrations, which were selected from the cytotoxicity tests of single 175 
stilbenes. The mean effective concentration (EC50) values obtained for the most 176 
sensitive endpoint at 24 h were chosen as the highest exposure concentrations, along 177 
with EC50/2 and EC50/4 fractions. Thus, cells were exposed for 24 h and 48 h to binary 178 
pure stilbenes mixtures: EC50 trans-resveratrol + EC50 trans-ε-viniferin, EC50/2 trans-179 




viniferin. Moreover, each concentration used in the combinations was evaluated alone. 181 
All experiments were performed by triplicate. 182 
The isobologram analysis was carried out as described in Tatay et al. (2014), with 183 
modifications (Gutiérrez-Praena et al., 2019).  184 
According to Chou and Talalay (1984) and Chou (2006), the isobologram analysis 185 
involves plotting the concentration-effect curves for each compound and its 186 
combinations in multiple diluted concentrations by using the median-effect equation.  187 
fa/fu = (D/Dm)
m 188 
D is the concentration of the stilbene, Dm the median-effect dose, fa is the fraction 189 
affected by D, fu is the unaffected fraction, and m is the coefficient signifying the shape 190 
of the dose–effect relationship. The method considers both the potency (Dm) and the 191 
shape (m).  192 
This single-dose equation can be extended for a multiple combination of stilbenes as 193 
follows: 194 
[(fa)1,2 / (fu) 1,2] 
1/m = D1 /(Dm)1 + D2/ (Dm)2 + (D)1 (D)2 / (Dm)1 (Dm)2 195 
This method provides the combination index (CI), which is useful for the quantification 196 
of synergism, additivity or antagonism of two compounds.  197 
CI = D1 / (Dx) 1 + D2/ (DX) 2  198 
Dx= Dm [fa/ (1-fa)]
 1/m 199 
CI= (D)1 / (Dm)1[fa/(1-fa)]
1/m1 + (D)2/(Dm)2 [fa/(1-fa)]
1/m2 200 
(Dx) 1 and (Dx) 2 are for D1 and D2 alone, respectively, that present a % effect on a 201 
system. When the CI < 1, this suggests synergism; when CI is =1, it indicates additivity; 202 
and when CI is >1, it refers antagonism. The CI50, CI75 and CI90 are the CI values at 203 
50%, 75% and 90% inhibition, respectively. These CI values were calculated by the 204 
CalcuSyn software (version 2.1.) (Biosoft, Cambridge, UK, 1996–2007). The 205 




and the linear correlation coefficient of the median-effect plot, respectively, and they 207 
give information about the shape of the concentration–effect curve.  208 
 209 
2.6. Morphological study under transmission electron microscope 210 
Electron microscope observations were performed according to Gutiérrez-Praena et al. 211 
(2019). Cultured cells were exposed to three different concentrations of the extract and 212 
the mixture, the EC50 value and their fractions (EC50/2, EC50/4). HepG2 were exposed 213 
to 31.91, 15.95, and 7.98 µg/ml for the extract; and 29.47, 14.73, and 7.37 µg/ml for the 214 
mixture. 215 
 216 
2.7. Calculations and statistical analysis  217 
Data for the concentration-dependent cytotoxicity relationships of all experiments were 218 
expressed as the arithmetic mean percentage ± standard deviation (SD) in relation to 219 
control. Statistical analysis performed was the analysis of variance (ANOVA), and 220 
further the Dunnett’s multiple comparison tests was used. The normality of the 221 
distribution and the homogeneity of variances were confirmed using Kolmogorov and 222 
Smirnov’s test, and Bartlett´s test, respectively. All the analysis was carried out using 223 
GraphPad InStat software (GraphPad Software Inc., La Jolla, USA). Differences were 224 
considered significant in respect to the control group at p < 0.01 (*), p < 0.05 (**) and at 225 
p < 0.01 (***). EC50 values were achieved by linear regression in the concentration-226 
response curves. 227 
 228 
3. Results 229 
3.1. Cytotoxicity studies of ST-99, individual stilbenes and their mixture. 230 
The EC50 values corresponding to the cytotoxicity assays of HepG2 and Caco-2 cells 231 
exposed to ST-99 extract, individual stilbenes and their mixture are shown in table 1. In 232 




because the highest concentration assayed (50 µg/mL) at 24 h did not reduce cell 234 
viability below 50%. In the other exposures, the EC50 values selected to be included in 235 
the table 1 were lowest found in each endpoint. 236 
Table 1. Cytotoxicity of the stilbenes extract, trans-ε-viniferin, trans-resveratrol and its 237 
mixture on the selected biomarkers according to EC50 values (µg/ml). 238 
 239 
HepG2 cells exposed to the extract underwent a time-dependent decrease in all the 240 
endpoints studied. The MTS assay showed significant changes respect to the control 241 
from 30 µg/mL for 24 h and 48 h. Moreover, TP in HepG2 cells exposed to the extract 242 
also indicated significant reduction in cellular viability from 40 µg/mL at 24 h and from 243 
30 µg/mL at 48 h. Similarly, NR uptake revealed marked decrease in cell viability at 40 244 
µg/mL after both exposure time (Fig. 1 A and B). The exposure to the mixture trans-245 
resveratrol/trans-ε-viniferin, in a proportion (1:3.9), caused a marked decreased in all 246 
endpoints in the hepatic cells. After 24h of exposure, significant changes were 247 
observed from 30 µg/mL, 50 µg/mL and 70 µg/mL by MTS, RN and PT assays, 248 
respectively (Fig. 1C). After 48h, MTS and TP showed a similar decrease in HepG2 249 
viability, being significant from 30 µg/mL (Fig. 1D). 250 
In the exposure of HepG2 to the single stilbenes, different results were obtained for 251 
each stilbene. While significant decreases were recorded in the case of trans-ε-viniferin 252 
at both exposure times from 30 µg/mL for 24 h and 20 µg/mL at 48 h (Fig. 2 A and B), 253 
trans-resveratrol did not induce a decrease higher than 50% in any of the tested 254 
concentrations (0-50 µg/mL) after 24 h of exposure (Fig. 2 C). At longer exposure time, 255 
a steady decrease of all the assays was also observed, showing significant results from 256 
35 µg/mL in TP assay and from 40 µg/mL in MTS metabolism and NR uptake assays 257 
(Fig. 2D). 258 
In Caco-2 cells exposed to the stilbene extract for 24 h and 48 h, all tested endpoints 259 




showing significant decreases from 20 µg/mL of the extract during 24 h and 48 h. RN 261 
assay revealed marked changes from 20 µg/mL and 30 µg/mL for 24 h and 48 h 262 
respectively. Similarly, MTS metabolism indicated significant differences from control 263 
after the exposure of 30 µg/mL for 24 h and from 20 µg/mL at 48 h (Fig. 3 A and B). In 264 
contrast, only after the exposure to 70 µg/mL of the mixture (1:3.9) changes respect to 265 
the control were observed at 24 h in all endpoints (Fig. 3 C). A concentration-266 
dependent decrease is also shown after 48 h of exposure to mixture. Both TP and MTS 267 
assays indicated significant differences from 40 µg/mL, while this effect was observed 268 
after the exposure to 50 µg/mL in the RN uptake assay (Fig. 3 D). 269 
When Caco-2 cells were exposed to trans-ε-viniferin, a concentration and time-270 
dependent decrease was recorded in all endpoints. MTS metabolism and PT content 271 
were remarkably reduced from 30 µg/mL after 24 h (Fig. 4 A). Similarly, the exposure 272 
from 40 µg/mL in colon cells affected RN uptake. After 48 h, 20 µg/mL of trans-ε-273 
viniferin caused significant reduction of cell viability in all three assays (Fig.4B). 274 
However, trans-resveratrol did not produce a reduction greater than 50% in Caco-2 275 
viability after 24 h at the concentrations assayed. Only after the exposure of the highest 276 
concentration tested (50 µg/mL), variations respect to the control were observed (Fig. 277 
4C). After 48 h of exposure, RN and TP assay revealed this decrease at 40 µg/mL, 278 
while MTS metabolism showed significant reductions at 50 µg/mL (Fig.4D). 279 
 280 
3.2. Isobologram analysis of stilbenes combination. 281 
The isobologram analysis is shown in the Figure 5, which represents the CI/fraction 282 
affected (fa) curves for stilbenes combination in both cell lines. The parameters Dm, m, 283 
and r of the combinations, and the mean CI values can be found in table 2. The mixture 284 
showed marked antagonistic effects at all concentrations assayed after 24 and 48 h in 285 
both cells. In the case of 48 h, the antagonist effect in more evident both in HepG2 and 286 





3.3. Electron microscopic observation in HepG2 cells 289 
Electron microscopic observation was only performed in HepG2 cells since they were 290 
most sensitive cells in comparison to Caco-2 cells. HepG2 cells exposed to the extract 291 
and the mixture of stilbenes underwent a concentration-dependent antiproliferative 292 
effect. A moderate decrease in cell proliferation was observed in the exposure to the 293 
lowest concentrations assayed (7.98 µg/ml for the extract and 7.37 µg/ml for the 294 
mixture). The exposure to 31.91 µg/ml of the ST-99 extract induced not only cell cycle 295 
arrest but also death cell evidenced by the presence of apoptotic bodies. These 296 
findings were also observed in the treatment with the highest concentration of the 297 
mixture, although in less frequency.  298 
In the ultrastructural study, control cells are characterized by big euchromatic nuclei 299 
with compact nucleoli (Fig. 6A). In the cytoplasm, cisternae from rough endoplasmic 300 
reticulum are linked to mitochondrial organelles. One of the most specific features of 301 
HepG2 cell line is the cellular interactions by zonula adherens, which define a surface 302 
coated with microvilli similar to bile ducts (Fig. 6B). These morphological features are 303 
also observed in the treatment to the lowest concentrations of the ST-99 extract (Fig. 304 
6C and 6D). Moreover, cells showing apoptotic nuclei (Fig. 6D). Cells treated with the 305 
highest concentration of the extract (31.91 µg/ml) showed more frequently 306 
cytoplasmatic projections that would turn into apoptotic bodies (arrow) (Fig. 6 F and 307 
6G). Similarly, an increase in the number of apoptotic cells was observed (Fig. 6H).   308 
When HepG2 cells were exposed to the lowest concentration of the mixture of 309 
stilbenes (7.37 µg/ml), they showed cytoplasmic evaginations (Fig. 7A and 7B) and 310 
apoptotic nuclei (Fig. 7C). These morphological features are also observed in cells 311 
exposed to 29.47 µg/ml of the stilbenes mixture (Fig. 7D), where nucleoli in the 312 
segregation process of their fibrilar and granular components is also shown evidencing 313 




experimental conditions cell proliferation is still active since mitotic cell are found (Fig. 315 
7F). 316 
 317 
4. Discussion 318 
New applications in the food industry for stilbenes could increase their intake making 319 
necessary a new risk assessment. In this regard, the first step would be to perform a 320 
cytotoxicity assay to stablish the potential concentrations suitable for its use in the food 321 
industry.  In the present work, the cytotoxic effect observed when HepG2 and Caco-2 322 
cells were exposed to ST-99 extract and the mixture of stilbenes were similar in 323 
general. Although, in the case of Caco-2 cells exposed to the mixture, lower effect was 324 
recorded at 24 h in comparison to the exposure to ST-99 extract. Similarly, several 325 
studies using different cell cultures have shown that treatment with stilbene extracts of 326 
different human cells: HepG2 and Caco-2 cells (Medrano-Padial et al., 2019), human 327 
lung cancer A-427 and human gastric adenocarcinoma CRL-1739 (Ye et al., 1999) and 328 
breast and liver tumour cell lines (Giovannelli et al., 2014), resulted in a dose and a 329 
time-dependent inhibition of cell growth. Moreover, in our study, although EC50 values 330 
for ST-99 extract and the mixture were similar, the concentration-effects curves were 331 
different. In both cell lines, ST-99 extract presented a very potent effect, while the 332 
decrease in the viability produced by the mixture was slowly progressive, especially 333 
after 24 h of exposure. The sharped curve obtained after the exposure to ST-99 could 334 
be related to the presence of different stilbenes, although some of them were only 335 
present in traces that could modulate enzymes and cell cycles having a great influence 336 
on toxicity (Xue et al., 2014). Similarly, Billard et al., (2002) also stated that the great 337 
antiproliferative effect of vineatrol® (a grapevine shoot extract containing 29% of 338 
stilbenes, mainly trans-resveratrol and ε-viniferin) is associated with the stilbenes that 339 




curve obtained after exposure ST-99 was similar to trans-ε-viniferin curve, probably 341 
because this stilbene is its main compound.  342 
The cytotoxic effects of the mayor compounds of ST-99 extract were also evaluated. 343 
The trans-ε-viniferin alone induced comparable cytotoxic effects to those observed for 344 
ST-99 extract and the mixture of stilbenes in both cell lines. However, HepG2 and 345 
Caco-2 cells exposed to trans-resveratrol underwent the lowest toxic effects observed 346 
in all exposures. Although most of literature addressed the antiproliferative and pro-347 
apoptotic effects of resveratrol by inhibiting the initiation step of tumour development 348 
(Gautam et al., 2000; Billard et al., 2002; Quiney et al., 2004; Notas et al., 2006; Müller 349 
et al., 2009; Ha et al., 2009; Colin et al., 2008; Marel et al., 2008; Storniolo and 350 
Moreno, 2012),  in recent years, the natural resveratrol oligomer trans- ε-viniferin has 351 
been shown to be even more potent than trans-resveratrol in reducing the proliferation 352 
in a variety of human cells (Barjot et al. 2007; Xue et al., 2014; Zghonda et al., 2011). 353 
Both compounds modulate different enzymes that have a great influence on toxicity, 354 
being likely that the potency of the effects of these two compounds may be dependent 355 
on the cell type and/or the target molecule (Zghonda et al., 2011).  356 
The effect of single stilbenes alone is well characterized, but the toxicity of mixture of 357 
stilbenes is less studied so far. In this sense, preparations containing a mixture of 358 
polyphenols may exhibit potentiation or synergistic effects, as compared to any other 359 
polyphenol tested alone (Billard et al., 2002). Most authors have reported that the 360 
cytotoxic effect of trans-resveratrol is synergized by other stilbenes in a complex 361 
mixture. Recently,  Balasubramani et al. (2019) indicated a synergistic activity of 362 
stilbenes present in muscarine grape extract, being at least 10-fold more effective in 363 
inducing cell death than the pure compound resveratrol in several cancer cells. 364 
Similarly, Billard et al. (2002) and Colin et al. (2008) stated that vineatrol® exhibited a 365 
greater antiproliferative effect than trans-resveratrol and trans-ε-viniferin on lymphocytic 366 




resveratrol and trans-ε-viniferin together. In the present work, the isobologram analysis 368 
showed an antagonistic effect between trans-resveratrol and trans-ε-viniferin at all 369 
concentrations assayed after 24 h and 48 h. Similarly, Giovannelli et al. (2014) found 370 
that natural extract which had significant amount of viniferins, were in general less 371 
effective reaching from 20% to about 50% growth inhibition (HCC1500 and HCC195 372 
cells) at the highest concentration, whereas other extract containing less viniferins 373 
contents reached inhibition above 80%. Considering these observations, although they 374 
did not study the effect of binary mixtures, the existence of interactions between 375 
dimeric and monomeric stilbenes can be the reason of the lower inhibition observed in 376 
extract containing higher amount of stilbenes (Giovannelli et al., 2014). 377 
Finally, the present work completes the cytotoxicity assays with a morphological study 378 
in HepG2 cells. The ultrastructural study indicates that the treatment with the extract 379 
ST-99 induces a breakdown in the cell cycle by inhibiting cell proliferation. Moreover, 380 
cell death, mainly apoptosis, is also observed, especially at the higher concentrations 381 
assayed. This effect is minimized in the treatment with the mixture of stilbenes, where 382 
the proliferative activity of the cells is conserved but the induction of programmed cell 383 
death is considerably reduced. Similarly, acetylated analogs of resveratrol as well as 384 
the mixture of polyphenolic compounds known as vineatrol® affect cell cycle 385 
progression of human colon cancer cell lines (Colin et al., 2009). Also, different 386 
preparations of vineatrol® and resveratrol induced apoptosis in leukemic B cells, with ε-387 
viniferin only exhibiting slight effects (Billard et al., 2002). Studies on the multiple 388 
myeloma cell line U266 showed that ε-viniferin and resveratrol could regulate cell cycle 389 
by affecting different targets inducing apoptosis in a caspase-dependent manner by 390 






In conclusion, our results indicate a significant decrease in the viability of the human 394 
intestinal Caco-2 cells and liver HepG2 cells after exposure to ST-99 extract, trans-ε-395 
viniferin and its mixture with trans-resveratrol (1:3.9) in the cytotoxicity assays, while 396 
trans-resveratrol presented the lower effect. In addition, the type of interaction of trans-397 
resveratrol and trans-ε-viniferin was stablished by the isbolograms method reporting an 398 
antagonistic response. The ultra-structural alterations in HepG2 cells exposed to ST-99 399 
extract and the mixture evidenced that the cytotoxicity previously observed was due to 400 
a breakdown in the cell cycle by inhibiting cell proliferation and induction of apoptosis. 401 
These findings are of great concern not only because they contribute to increase the 402 
knowledge of these stilbenes but also because the ST-99 extract could be used as an 403 
alternative to SO2 in winemaking. Considering the toxicity observed in the in vitro 404 
assays performed, further studies are needed in order to assess the toxicity on human 405 
and ensure its safety.  406 
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Figure legends 594 
Figure 1. Reduction of tetrazolium salt (MTS), neutral rep uptake (NR) and total protein 595 
content (TP) of HepG2 cells exposed for 24 h (A) and 48 h (B) to 0-100 µg/mL of the 596 
stilbene extract ST-99, and exposed for 24 h (C) and 48 h (D) to 0-100 µg/mL of the 597 
stilbene mixture. All values expressed as mean ± SD. Significant differences in respect 598 
to the control from p<0.01 (**). 599 
Figure 2. Reduction of tetrazolium salt (MTS), neutral rep uptake (NR) and total protein 600 
content (TP) of HepG-2 cells exposed for 24 h (A) and 48 h (B) to 0-100 µg/mL of 601 
trans-ε-viniferin, and exposed for 24 h (C) and 48 h (D) to 0-50 µg/mL of trans-602 
resveratrol. All values expressed as mean ± SD. Significant differences in respect to 603 
the control from p<0.05 (*) and p<0.01 (**). 604 
Figure 3. Reduction of tetrazolium salt (MTS), neutral rep uptake (NR) and total protein 605 
content (TP) of Caco-2 cells exposed for 24 h (A) and 48 h (B) to 0-100 µg/mL of the 606 
stilbene extract ST-99, and exposed for 24 h (C) and 48 h (D) to 0-100 µg/mL of the 607 
stilbene mixture. All values expressed as mean ± SD. Significant differences in respect 608 
to the control from p<0.01 (**). 609 
Figure 4. Reduction of tetrazolium salt (MTS), neutral rep uptake (NR) and total protein 610 
content (TP) of Caco-2 cells exposed for 24 h (A) and 48 h (B) to 0-100 µg/mL of trans-611 
ε-viniferin, and exposed for 24 h (C) and 48 h (D) to 0-50 µg/mL of trans-resveratrol. All 612 
values expressed as mean ± SD. Significant differences in respect to the control from 613 
p<0.05 (*) and p<0.01 (**). 614 
Figure 5. Combination index (CI)/fraction affected (fa) curve in HepG2 cells exposed to 615 
a binary mixture of trans-ε-viniferin and trans-resveratrol for 24 h (A) and 48 h (B), and 616 
in Caco-2 cells exposed to the same mixture for 24 h (C) and 48 h (D). Each point 617 
represents the CI ± s.d. at a fractional effect. The dotted line (CI = 1) indicates 618 





Figure 6. Morphology of HepG2 cells exposed to 31.91, 15.95, and 7.98 µg/ml of the 621 
extract ST-99 after 24 h. Control HepG2 cells in normal growth with normal morphology 622 
showing big euchromatic nuclei (N) with compact nucleoli (n) (A). Cell treated with 7.98 623 
µg/ml of ST-99 developed cisternae from rough endoplasmic reticulum (rer) linked to 624 
mitochondrial organelles (m) (B). Cellular interactions (arrow head) with microvilli 625 
(arrow) are also observed (C). Cells showed cellular interactions (arrow) (D) and 626 
apoptotic nuclei (ApN) (E). Cells exposed to 31.91 µg/ml showed cytoplasmatic 627 
projections that would turn into apoptotic bodies (arrow) (F). Big lipid drops are also 628 
shown (Lip) (G). Increase in the number of apoptotic cells (ApN) (H). 629 
Figure 7. Morphology of HepG2 cells exposed to 29.47 (A, B, C) and 7.37 µg/ml of the 630 
mixture of stilbenes (D, E, F). HepG2 cells exposed to 7.37 µg/ml of the mixture of 631 
stilbenes showed cytoplasmic evaginations (arrow) (A, B) and apoptotic nuclei (ApN) 632 
(C). HepG2 treated with 29.47 µg/ml of the stilbenes mixture also showed apoptotic 633 
nuclei (ApN) and lipid drops (Lip) (D). At this concentration, the nucleoli (n) was in 634 
segregation process of their fibrillar (f) and granular (g) components (E). However, cell 635 
proliferation is still observed in mitotic process (Mit) (F). 636 




Table legend 638 
Table 1. Cytotoxicity of the stilbenes extract, trans-ε-viniferin, trans-resveratrol and its 639 
mixture on the selected biomarkers according to EC50 values (µg/ml). 640 
Table 2. The parameter m, Dm and r are the antilog of x-intercept, the slope and the 641 
linear correlation coefficient of the median-effect plot, which signifies the shape of the 642 
dose-effect curve, the potency (IC50), and the conformity of the data to the mass-action 643 













Time of exposure 
ST-99 extract 31.91 ± 1.55 27.79 ± 2.35 24h 
26.58 ± 2.00 19.29 ± 1.02 48h 
Mixture 29.47 ± 3.54 74.34 ± 2.40 24h 
26.57 ± 1.92 38.67 ± 2.02 48h 
Trans-Ɛ-viniferin 28.28 ± 2.15 36.72 ± 3.01 24h 
17.85 ± 3.03 20.63 ± 1.25 48h 
Trans-resveratrol >50 >50 24h 
39.56 ± 2.41 48.89 ± 2.99 48h 
 
 
Stilbene Time Dm (µg/mL) m r Time Dm (µg/mL) m r 
trans-resveratrol 24h 
48h 
49.09 
58.49 
0.98 
2.00 
0.98 
0.99 
24h 
48h 
64.70 
90.19 
1.90 
1.38 
0.99 
0.96 
trans-Ɛ-viniferin 24h 
48h 
39.51 
17.84 
1.60 
1.44 
0.96 
1.00 
24h 
48h 
39.29 
23.30 
1.10 
1.39 
0.99 
0.99 
Mixture 24h 
48h 
59.72 
60.80 
1.00 
1.22 
0.99 
0.97 
24h 
48h 
61.99 
67.35 
1.26 
1.20 
0.99 
0.99 
HepG2 
Caco-2 
HepG2 Caco-2 
